Yingzhou Tian

No ORCID on file · 4 papers in corpus
meta-analysis 2026
Frontiers in medicine ·doi:10.3389/fmed.2026.1776698

OBJECTIVE: To systematically evaluate the efficacy and safety of blood-invigorating and stasis-resolving Chinese herbal medicines (BISMs) when combined with conventional clinical therapy for endometriosis, and to provide evidence-based guid…

lab-animal 2026
Tissue & cell ·doi:10.1016/j.tice.2026.103581

Adenomyosis (ADM) is a benign condition associated with various gynecological disorders. However, effective treatment options are limited, highlighting the urgent need for novel therapeutic targets. This study identified abnormal activation…

lab-animal 2025
Frontiers in pharmacology ·doi:10.3389/fphar.2025.1691279

Endometriosis (EMs) is an estrogen-dependent chronic inflammatory disease. While apoptosis resistance (evidenced by Bcl-2 upregulation and Bax/caspase-3 downregulation) remains a hallmark of EMs, recent studies reveal a paradoxical coexiste…

2019
·doi:10.21203/rs.2.9951/v1

Abstract Endometriosis and adenomyosis are two of the most common causes of secondary dysmenorrhea and often lead to a deterioration in the quality of life. Traditional Chinese medicine and acupuncture are widely used in the treatment of me…